Pooled data from three large European cohorts also show that participants in the top tertile of copeptin have higher fasting plasma glucose compared to the bottom and medium tertiles, and are more likely to have type 2 diabetes (T2DM) [54]. Here, AVP is linked to type 2 diabetes mellitus.